The specialty pharmacy space has proven to be a rewarding investment for private equity, as specialty medications typically lead the pharmacy trend cost curve, which will only continue as more than 60 new specialty medications expected to receive... Read More
Blogs & Articles | COVID-19 Resources | DIR Fees | Life Sciences | Private Equity Investing in Specialty Pharmacy & Pharmaceutical Companies | Specialty Pharmacies

It was recently announced that Amazon will be acquiring the online pharmacy, PillPack, for approximately $1 billion, with each of the founders receiving approximately $100 million each. PillPack's rise and success is one that all pharmacy owners... Read More
Blogs & Articles | Out-of-Network Provider Issues | Pharmacy Law | Private Equity Investing in Specialty Pharmacy & Pharmaceutical Companies

Download the webinar slides. The specialty pharmacy industry has dramatically changed over the past few years and is now one of the fastest growing sources of revenue in the prescription drug marketplace. As a result, payers and PBMs... Read More
Defending Pharmacies in PBM Audits | DIR Fees | Pharmacy Law | Private Equity Investing in Specialty Pharmacy & Pharmaceutical Companies

In an industry where supply chains are closely monitored, patient data is king, and complex medications require high-touch services by distribution partners, biologics and pharmaceutical manufacturers have turned to specialty pharmacies to assist.... Read More
Life Sciences | Manufacturers | Pharmacy Law | Private Equity Investing in Specialty Pharmacy & Pharmaceutical Companies

Pharmaceutical Manufacturers are facing heightened public and legal scrutiny when it comes to the pricing of Specialty Pharmacy drugs. The issue was thrust into the spotlight in recent months as private Hedge Funds have purchased small Specialty... Read More
Pharmacy Law | Private Equity Investing in Specialty Pharmacy & Pharmaceutical Companies